X0306 4 2019-12-05 0 0001595893 Turning Point Therapeutics, Inc. TPTX 0001772259 Cui Jingrong Jean C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121 1 1 0 0 Chief Scientific Officer Common Stock 1301298 D Common Stock 2019-12-05 4 S 0 21280 50.93 D 1157939 I By spouse Common Stock 2019-12-05 4 S 0 12200 52.08 D 1145739 I By spouse Common Stock 2019-12-05 4 S 0 22630 52.84 D 1123109 I By spouse Common Stock 2019-12-06 4 S 0 36627 50.67 D 1086482 I By spouse Common Stock 2019-12-06 4 S 0 14263 51.02 D 1072219 I By spouse Common Stock 2019-12-09 4 S 0 3000 54.33 D 1069219 I By spouse Common Stock 2019-12-09 4 S 0 4100 55.35 D 1065119 I By spouse Common Stock 2019-12-09 4 S 0 4200 55.94 D 1060919 I By spouse Common Stock 2019-12-09 4 S 0 200 56.78 D 1060719 I By spouse Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li. The weighted average sale price for the transaction reported was $50.93, and the range of prices were between $50.48 and $51.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $52.08, and the range of prices were between $51.49 and $52.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $52.84, and the range of prices were between $52.495 and $53.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $50.67, and the range of prices were between $49.90 and $50.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $51.02, and the range of prices were between $50.905 and $51.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $54.33, and the range of prices were between $53.67 and $54.67. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $55.35, and the range of prices were between $54.70 and $55.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $55.94, and the range of prices were between $55.74 and $56.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $56.78, and the range of prices were between $56.75 and $56.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. /s/ Annette North, Attorney-in-Fact 2019-12-09